|
Market Closed -
OTC Markets
23:12:15 28/07/2025 +04
|
5-day change | 1st Jan Change | ||
| 30.92 USD | +24.45% |
|
-.--% | - |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.92% | 1.08% | 34.18x | 4.79x | 6.41x | 22.23x | 26.92x | 46.37B | |
| 1.69% | 1.82% | 15.96x | 1.78x | 1.97x | 8.77x | 11.13x | 37.26B | |
| 0.56% | 0.59% | 28.87x | 3.97x | 4.1x | 17.01x | 23.82x | 12.53B | |
| 0.93% | 1.05% | 27.25x | 3.01x | 3.31x | 17.13x | 21.98x | 11.8B | |
| 3.79% | 3.98% | 18.58x | 3.38x | 3.37x | 11.75x | 13.98x | 8.97B | |
| 4.84% | 5.42% | 9.18x | 1.51x | 2.12x | 5.48x | 6.66x | 7.09B | |
| 0.16% | 0.17% | 28.95x | 5.31x | 3.78x | 17.59x | 21.21x | 7.01B | |
| 3.21% | 3.18% | 15.51x | 1.29x | 2.06x | 6.85x | 9.72x | 7.29B | |
| 0.98% | 1.14% | 35.39x | 8.18x | 6.9x | 25.23x | 27.85x | 4.62B | |
| 1.69% | 1.57% | 15.95x | 0.78x | 2.2x | 9.4x | 11.89x | 4.27B | |
| 3.76% | 4.27% | 13.91x | 2.31x | 2.29x | 10.31x | 10.14x | 3.66B | |
| 3.07% | 3.19% | 15.87x | 2.81x | 3.21x | 12.08x | 14.41x | 2.77B | |
| 3.22% | 3.65% | 18.76x | 4.76x | 5.34x | 16.01x | 17.52x | 2.42B | |
| Average | 2.22% | 2.39% | 21.41x | 3.38x | 3.62x | 13.83x | 16.71x | 12B | |
| Weighted average by Cap. | 1.66% | 1.8% | 24.23x | 3.40x | 3.97x | 15.10x | 18.66x |
- Stock Market
- Stocks
- RICHTER Stock
- GEDSF Stock
- Sector Gedeon Richter
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
